- Joined
- Mar 20, 2013
- Messages
- 1,920
- Reaction score
- 3,534
Thanks a lot! 4 surprised me, unless I guess you mean for prostate. The standard of care should incentivize people to use brachy for gyn. If reimbursement is a barrier that is news to me and that sucks!
For 2, I guess reasonable people can disagree. APEx and $12,000 every 3 years is a higher burden than MIPS. Much higher. Unless you're already accredited. We are doing this now and its a huge burden and basically our whole team feels its a waste of time.
AGree the APEX thing is a disaster. When you get a captive audience too, that price will only go up, too.
I think MOST important whether we remain FFS or ROCR is index to inflation. whoever/however that can happen will have my vote.
As a measure of good faith, I would like to see proton for prostate and breast to be a flat rate *unless on a randomized trial.*